Publications by authors named "Tom Manley"

Claim this Profile
T
Treating Early-Stage CKD With New Medication Therapies: Results of a CKD Patient Survey Informing the 2020 NKF-FDA Scientific Workshop on Clinical Trial Considerations for Developing Treatments for Early Stages of Common, Chronic Kidney Diseases.
Kelli Collins Damron, Robert Friedman, Lesley A Inker, Aliza Thompson, Morgan E Grams, Tom Manley

Kidney Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing use of SGLT2 inhibitors and other evidence-based therapies to improve outcomes in patients with type 2 diabetes and chronic kidney disease: An opportunity for pharmacists.
Joshua J Neumiller, Jay H Shubrook, Tom Manley, Radica Z Alicic, Katherine R Tuttle

Am J Health Syst Pharm· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experience with transplantation of human cryopreserved ovarian tissue to a sub-peritoneal abdominal site.
Debra Gook, Lyndon Hale, Alex Polyakov, Tom Manley, Genia Rozen

Hum Reprod· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
Katherine R Tuttle, Frank C Brosius, Matthew A Cavender, Paola Fioretto, Kevin J Fowler, Tom Manley

Diabetes· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
Katherine R Tuttle, Frank C Brosius, Matthew A Cavender, Paola Fioretto, Kevin J Fowler, Tom Manley

Am J Kidney Dis· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency.
Andrew S Levey, Ron T Gansevoort, Josef Coresh, Lesley A Inker, Hiddo L Heerspink, Tom Manley

Am J Kidney Dis· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts.
Brad C Astor, Kunihiro Matsushita, Ron T Gansevoort, Marije van der Velde, Mark Woodward, Tom Manley

Kidney Int· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts.
Marije van der Velde, Kunihiro Matsushita, Josef Coresh, Brad C Astor, Mark Woodward, Tom Manley

Kidney Int· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis